Reminder: Invitation to Roche's Half Year Results 2018, Thursday 26th July 2018 - Live video webcast and conference call Donnerstag, 19. Juli 2018 - 10:04

Roche will publish its Half Year Results for 2018 prior to the opening of the Swiss Stock Exchange on Thursday, 26th July 2018.

7:00 CEST / 6:00 BST / 1:00 AM EDT / 10:00 PM PDT (evening before)
Release will be e-mailed and posted on the Roche IR website click here.
Presentation slides will be posted on the Roche IR website click here.

We would like to invite you to watch the live video webcast or to dial in as outlined below:

Thursday, 26th July, 2018

13:00 - 14:30 CEST / 12:00 - 13:30 BST
07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT

Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).

Presenters:

Severin Schwan, CEO Roche Group
Alan Hippe, Chief Financial and IT Officer
Daniel O'Day, CEO Roche Pharmaceuticals
Roland Diggelmann, CEO Roche Diagnostics

To access the live video webcast, please click here

To listen to the conference call, please dial in to the conference 10-15 min prior to the scheduled start, using the following numbers:
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

To expedite the registration process on the day of the conference call, you may pre-register for the event> click here: 

A replay of the webcast will be available on demand on the Roche website. > click here

Best regards,

Karl Mahler
Head of Investor Relations

Roche Investor Relations

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Susann Manchado
Phone: +41 61-68-75619
e-mail: susann.manchado@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com